Helicobacter pylori interpretation in 2022

Labigne A, de Reuse H. Determinants of Helicobacter pylori pathogenicity. Infect Agents Dis. 1996;5(4):191-202. [PMID: 8884364]

McColl KE. Helicobacter pylori: clinical aspects. J Infect. 1997;34(1):7-13. [PMID: 9120329 DOI: 10.1016/s0163-4453(97)80003-5]

Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;1(8390):1311-1315. [PMID: 6145023 DOI: 10.1016/s0140-6736(84)91816-6]

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. [PMID: 30207593 DOI: 10.3322/caac.21492]

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum. 1994;61:1-241. [PMID: 7715068]

Moss SF. The clinical evidence linking Helicobacter pylori to gastric cancer. Cell Mol Gastroenterol Hepatol. 2017;3(2):183-191. [PMID: 28275685 DOI: 10.1016/j.jcmgh.2016.12.001]

Tacconelli E, Carrara E, Savoldi A, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318-327. DOI: 10.1016/S1473-3099(17)30753-3 PMID: 29276051

Dang BN, Graham DY. Helicobacter pylori infection and antibiotic resistance: a WHO high priority? Nat Rev Gastroenterol Hepatol. 2017;14(7):383-384. [PMID: 28465548 DOI: 10.1038/nrgastro.2017.57]

O'Mahony R, Al-Khtheeri H, Weerasekera D, et al. Bactericidal and anti-adhesive properties of culinary and medicinal plants against Helicobacter pylori. World J Gastroenterol. 2005;11(47):7499-7507. [PMID: 16437723 DOI: 10.3748/wjg.v11.i47.7499]

Sari YS, Can D, Tunali V, Sahin O, Koc O, Bender O. H pylori: treatment for the patient only or the whole family? World J Gastroenterol. 2008;14(8):1244-127. [PMID: 18300351 DOI: 10.3748/wjg.14.1244]

Elshair M, Ugai T, Oze I, et al. Impact of socioeconomic status and sibling number on the prevalence of Helicobacter pylori infection: a cross-sectional study in a Japanese population. Nagoya J Med Sci. 2022;84(2):374-387. [PMID: 35967946 DOI: 10.18999/nagjms.84.2.374]

Genta RM, Turner KO, Sonnenberg A. Demographic and socioeconomic influences on Helicobacter pylori gastritis and its pre-neoplastic lesions amongst US residents. Aliment Pharmacol Ther. 2017;46(3):322-330. [PMID: 28547755 DOI: 10.1111/apt.14162]

Malfertheiner P, Camargo MC, El-Omar E, et al. Helicobacter pylori infection. Nat Rev Dis Primers. 2023;9(1):19. [PMID: 37081005 DOI: 10.1038/s41572-023-00431-8]

Windsor HM, Abioye-Kuteyi EA, Leber JM, Morrow SD, Bulsara MK, Marshall BJ. Prevalence of Helicobacter pylori in Indigenous Western Australians: comparison between urban and remote rural populations. Med J Aust. 2005;182(5):210-213. [PMID: 15748129 DOI: 10.5694/j.1326-5377.2005.tb06668.x]

Wise MJ, Lamichhane B, Webberley KM. A longitudinal, population-level, big-data study of Helicobacter pylori-related disease across western Australia. J Clin Med. 2019;8(11):1821. [PMID: 31683830 DOI: 10.3390/jcm8111821 ]

Australian Institute of Health and Welfare. Stomach cancer statistics. Accessed March, 23 2021. https://www.wcrf.org/cancer-trends/stomach-cancer-statistics

Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249. [PMID: 33538338 DOI: 10.3322/caac.21660]

Higashi H, Tsutsumi R, Fujita A, et al. Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci U S A. 2002;99(22):14428-14433. [PMID: 12391297 DOI: 10.1073/pnas.222375399]

Olbermann P, Josenhans C, Moodley Y, et al. A global overview of the genetic and functional diversity in the Helicobacter pylori cag pathogenicity island. PLoS Genet. 2010;6(8):e1001069. [PMID: 20808891 DOI: 10.1371/journal.pgen.1001069]

Censini S, Lange C, Xiang Z, et al. Cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci U S A. 1996;93(25):14648-14653. [PMID: 8962108 DOI: 10.1073/pnas.93.25.14648]

Posselt G, Backert S, Wessler S. The functional interplay of Helicobacter pylori factors with gastric epithelial cells induces a multi-step process in pathogenesis. Cell Commun Signal. 2013;11:77. [PMID: 24099599 DOI: 10.1186/1478-811X-11-77]

Umehara S, Higashi H, Ohnishi N, Asaka M, Hatakeyama M. Effects of Helicobacter pylori CagA protein on the growth and survival of B lymphocytes, the origin of MALT lymphoma. Oncogene. 2003;22(51):8337-8342. [PMID: 14614457 DOI: 10.1038/sj.onc.1207028]

Murata-Kamiya N, Kurashima Y, Teishikata Y, et al. Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells. Oncogene. 2007;26(32):4617-4626. [PMID: 17237808 DOI: 10.1038/sj.onc.1210251]

Allison R, Lecky DM, Bull M, Turner K, Godbole G, McNulty CAM. Audit of Helicobacter pylori testing in microbiology laboratories in England: to inform compliance with NICE guidance and the feasibility of routine antimicrobial resistance surveillance. Int J Microbiol. 2016;2016:8540904. [PMID: 27829836 DOI: 10.1155/2016/8540904]

Llorca-Otero L, Toro-Rueda C. Diagnosis of Helicobacter pylori infection: progress and challenges. Enferm Infecc Microbiol Clin (Engl Ed). 2020;38(9):407-409. [PMID: 33169695 DOI: 10.1016/j.eimc.2020.09.008]

Zullo A, Francesco V, Gatta L. Helicobacter pylori culture: from bench to bedside. Ann Gastroenterol. 2022;35(3):243-248. [PMID: 35599931 DOI: 10.20524/aog.2022.0703]

Marshall BJ, Armstrong JA, Francis GJ, Nokes NT, Wee SH. Antibacterial action of bismuth in relation to Campylobacter pyloridis colonization and gastritis. Digestion. 1987;37 Suppl 2:16-30. [PMID: 3622946 DOI: 10.1159/000199555]

McNicholl AG, Bordin DS, Lucendo A, et al. Combination of bismuth and standard triple therapy eradicates Helicobacter pylori infection in more than 90% of patients. Clin Gastroenterol Hepatol. 2020;18(1):89-98. [PMID: 30978536 DOI: 10.1016/j.cgh.2019.03.048]

Kumar S, Metz DC, Ellenberg S, Kaplan DE, Goldberg DS. Risk factors and incidence of gastric cancer after detection of Helicobacter pylori infection: a large cohort study. Gastroenterology. 2020;158(3):527-536.e7. [PMID: 31654635 DOI: 10.1053/j.gastro.2019.10.019]

Leung WK, Wong IOL, Cheung KS, et al. Effects of Helicobacter pylori treatment on incidence of gastric cancer in older individuals. Gastroenterology. 2018;155(1):67-75. [PMID: 29550592 DOI: 10.1053/j.gastro.2018.03.028]

Choi IJ, Kim CG, Lee JY, et al. Family history of gastric cancer and Helicobacter pylori treatment. N Engl J Med. 2020;382(5):427-436. [PMID: 31995688 DOI: 10.1056/NEJMoa1909666]

Fahey JW, Stephenson KK, Wallace AJ. Dietary amelioration of Helicobacter infection. Nutr Res. 2015;35(6):461-473. [PMID: 25799054 DOI: 10.1016/j.nutres.2015.03.001]

Graham DY, Anderson SY, Lang T. Garlic or jalapeño peppers for treatment of Helicobacter pylori infection. Am J Gastroenterol. 1999;94(5):1200-1202. [PMID: 10235193 DOI: 10.1111/j.1572-0241.1999.01066.x]

O'Mahony R, Al-Khtheeri H, Weerasekera D, et al. Bactericidal and anti-adhesive properties of culinary and medicinal plants against Helicobacter pylori. World J Gastroenterol. 2005;11(47):7499-7507. [PMID: 16437723 DOI: 10.3748/wjg.v11.i47.7499]

Graham DY. The only good Helicobacter pylori is a dead Helicobacter pylori. Lancet. 1997;350 (9070):70-71. [PMID: 9217742 DOI: 10.1016/S0140-6736(05)66278-2]